Prenatal diagnosis method on isolated foetal cell of maternal blood
CA 2452099 C · Owner: Paterlini-Brechot, Patrizia · Inventors: Paterlini-Brechot, Patrizia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a novel non-invasive prenatal diagnostic method implemented with a sample of maternal blood. Said method enables prenatal diagnosis on isolated non-apoptotic epithelial foetal cells of maternal blood after they have been enriched by filtration morphologically or immunologically and genetically analysed. Said method is advantageous in that it is perfectly harmless for the mother and the foetus and provides a highly sensitive and specific diagnosis. It enables early detection of a genetic or chromosomal abnormality of the foetus of a genetic or infectious (viral, bacterial or parasitic) pathology of the foetus of accurate genotype, and in particular of the genetic sex …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 30, 2002 and granted May 9, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.